Institute Of Tropical Medicine, Belgium

This study checks if a single rabies booster shot can still protect people who got their first rabies vaccine at least 5 years ago. About 561 healthy adults will get a booster, and researchers will measure their immune response after 7 days. The goal is to see if different initia…

This Phase 3 trial in Ethiopia will compare four different drug regimens against the standard treatment for cutaneous leishmaniasis, a parasitic skin disease. 900 patients aged 4 to 65 will be hospitalized and treated for up to 28 days, with follow-up for 6 months. The goal is to…

This study evaluates a new diagnostic test called DECIPHER bioassay for detecting Ebola virus. Researchers will use stored blood and cheek swab samples from patients in the Democratic Republic of the Congo to see how well the new test compares to the standard lab method. The goal…

This study evaluates two new diagnostic tests (FORTIFIEDx and DECIPHER) for detecting Ebola and Lassa viruses. Researchers will use stored blood and cheek swab samples from patients in Guinea to see how well these tests compare to the standard PCR method. The goal is to determine…

This study will test a new rapid diagnostic test for plague in the Ituri province of DR Congo. Researchers will collect samples like blood, saliva, and bubo fluid from 300 people with suspected plague to see how well the new test works compared to standard lab methods. The goal i…

This observational study will follow 95 adults who receive a booster dose of the MVA-BN vaccine against mpox. Researchers will collect blood and other samples over two years to measure antibody and immune cell responses. The goal is to understand how long the booster's protection…